Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
26.53
-0.60 (-2.21%)
Apr 25, 2025, 12:04 PM EDT - Market open
Azenta Revenue
Azenta had revenue of $147.51M in the quarter ending December 31, 2024, with 4.08% growth. This brings the company's revenue in the last twelve months to $662.11M, up 5.36% year-over-year. In the fiscal year ending September 30, 2024, Azenta had annual revenue of $656.32M, down -1.32%.
Revenue (ttm)
$662.11M
Revenue Growth
+5.36%
P/S Ratio
2.07
Revenue / Employee
$200,639
Employees
3,300
Market Cap
1.21B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 656.32M | -8.75M | -1.32% |
Sep 30, 2023 | 665.07M | 109.57M | 19.73% |
Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
AZTA News
- 20 hours ago - Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast - PRNewsWire
- 4 weeks ago - Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report - PRNewsWire
- 6 weeks ago - Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum - PRNewsWire
- 2 months ago - Azenta, Inc. (AZTA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 - PRNewsWire
- 3 months ago - Azenta Announces the Election of Dipal Doshi to its Board of Directors - PRNewsWire
- 3 months ago - Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast - PRNewsWire
- 3 months ago - UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence - PRNewsWire